Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRIP and coiled-coil domain-containing protein 2 (GCC2) is a peripheral membrane protein that localizes to the trans-Golgi network (TGN), characterized by a C-terminal GRIP domain involved in targeting and extensive coiled-coil regions. It is thought to regulate vesicular transport between endosomes and the Golgi by functioning as a tethering factor, especially in the recycling of the mannose 6-phosphate receptor from late endosomes to the TGN. GCC2 is also implicated in maintaining the organization, structure, and function of the Golgi apparatus, in part via recruitment of microtubule-stabilizing proteins. Mutations or dysregulation have been associated with certain cancers and Charcot-Marie-Tooth disease (axonal, type 2Z)[3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRIP and coiled-coil domain-containing protein 2 (GCC2).